Asthma In-Home Monitoring (AIM) Trial

NCT00282516 | Completed

• 1 other identifier: 28H01
• Study Type: interventional
• Target: 120
• Locations: 1 country
• Sites: 1

Brief Summary

OBJECTIVE: Determine whether home asthma telemonitoring using store-and-forward technology improves outcomes when compared to in-person, office-based visits.

Conditions

Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines

Keywords

asthma; telemedicine; case management; clinic; children; pediatric

Interventions

In-home telemonitoring of pediatric patients with persistent asthma PROCEDURE

Eligibility Criteria

• Age: 6 Years - 17 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Diagnosis of persistent asthma as defined using the NHLBI Expert Panel Report -2 guidelines Assignment of severity classification will be made at the beginning of the study based on severity of disease off therapy.
• Dependent of active duty or retired US military personnel
• to 17 years of age
• Not moving from Oahu for 12 months after entry into study
• Ability to receive cable modem hook-up in home
• Willingness to learn to record and send MDI + spacer technique and peak flow two times week
• Willing to attend asthma education follow-up visits either in person or electronically at 2- weeks, 6- weeks, 3-months and 6-month intervals after initiation into the study.
• Willing to complete survey at the end of study period.
• Willing to sign informed, written consent

You may not qualify if:

• Diagnosis of mild intermittent asthma as defined by Expert Panel Report -2 guidelines.
• \<6 and \>17 years of age
• Family leaving Oahu within 12 months
• Inability to receive cable modem hook-up in home
• Unwilling or unable to learn to record and send MDI + spacer technique and peak flow and/or to attend asthma education follow-up visits either in person or electronically at initiation into study and at 2- weeks, 6- weeks, 3-months and 6 month intervals.
• Unwilling to complete survey at the end of study period.
• Patients or parents who decline to participate.
• Patients with other chronic pulmonary disease (cystic fibrosis, bronchopulmonary dysplasia)

Sponsors & Collaborators

• Tripler Army Medical Center: lead
• U.S. Army Medical Research Acquisition Activity: collaborator

Study Sites (1)

Tripler Army Medical Center

Tripler AMC, Hawaii, 96859-5000, United States

Location

MeSH Terms

Conditions

Lymphoma, Follicular; Asthma

Condition Hierarchy (Ancestors)

Lymphoma, Non-Hodgkin; Lymphoma; Neoplasms by Histologic Type; Neoplasms; Lymphoproliferative Disorders; Lymphatic Diseases; Hemic and Lymphatic Diseases; Immunoproliferative Disorders; Immune System Diseases; Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity

Study Officials

• Charles W Callahan, DO

  Chief, Department of Pediatrics, Tripler Army Medical Center

  PRINCIPAL INVESTIGATOR

• Debora S Chan, PharmD

  Department of Pediatrics, Tripler Army Medical Center

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: FED
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 25, 2006
• First Posted: January 26, 2006
• Study Start: April 1, 2003
• Primary Completion: April 1, 2004
• Study Completion: April 1, 2004
• Last Updated: February 10, 2025

Record last verified: 2025-02

Locations

US (1)